Recent Finacing
Recent Raise
Annexon is a clinical-stage biopharmaceutical developing C1q-targeting antibodies and Fabs to treat classical complement–mediated disorders of the body, brain, and eye, using biomarker-driven trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
